WMU HOME > ABOUT WMU > WMU NEWS
Luderer takes reins at BRCC
May 16, 2005
KALAMAZOO--Dr. Jack R. Luderer is the new executive director of Western Michigan University's Biosciences Research and Commercialization Center, effective today.
Luderer, who has served as WMU's vice president for research since 2002, was a key figure in securing state funding for the center two years ago and developing the center's structure and business plan. He replaces Dr. Charles Nawrot, who was named to head the center in October but recently decided to remain in California where he has lived for several years.
Dr. Judith I. Bailey, president of Western Michigan University, informed the university community of Luderer's new post in a campuswide e-mail May 12. The decision to appoint Luderer to the position was made by the BRCC's Board of Governors when it met last month. Both Luderer and Bailey serve on that board.
Nawrot's decision to withdraw from the post, Bailey said, "left vacant a leadership position that is essential to the success of the BRCC and to the future of economic development in the state. The question then became how best to provide experienced leadership that would ensure the BRCC would continue to function smoothly with minimal disruption to its momentum."
Luderer, she noted, "is not only thoroughly familiar with the creation of the BRCC, but highly regarded in the life sciences."
To focus on his new role, Bailey said, Luderer has resigned as vice president for research, and WMU will immediately begin a national search for his replacement. The search committee will be led by Robert M. Beam, vice president for business and finance. Dr. Leonard Ginsberg, associate vice president for research, will assume administrative responsibility for WMU's research area during the search.
Luderer first came to WMU in 2000 as associate vice president
for research. Prior to joining the WMU administration, he was
vice president of U.S. Medical Affairs at Pharmacia Corp., which
is now part of Pfizer Inc. A medical doctor who has published
more than 100 articles, abstracts and technical reports, Luderer
came to Kalamazoo in 1984 to work for the Upjohn Co. He held
several positions with that firm, including executive director
of clinical pharmacology, vice president of clinical pharmacology
and vice president of clinical development.
Before joining Upjohn, he was an assistant professor of medicine
and pharmacology at the Milton S. Hershey Medical Center of Pennsylvania
State University. Luderer earned a bachelor's degree in chemistry
from Miami University. He went on to earn a master's degree in
organic chemistry at Miami and a medical degree from Northwestern
University Medical School.
Media contact: Cheryl Roland, 269 387-8400, cheryl.roland@wmich.edu
WMU News
Office of University Relations
Western Michigan University
1903 W Michigan Ave
Kalamazoo MI 49008-5433 USA
269 387-8400
www.wmich.edu/wmu/news